GLP-1 Market
LLY $1184.78 ▲ +0.1% NVO $38.71 ▼ -0.2% PFE $28.72 ▲ +0.2% VKTX $33.03 ▼ -7.1% KLRA $11.12 ▼ -0.9% GPCR $35.06 ▼ -2.4% RHHBY $53.34 ▼ -2.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Velpatasvir

Company
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
6 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

6 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 29, 2026

Find a Clinical Trial Near Me

See recruiting studies for Velpatasvir and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03383419

    Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients

    Not yet reported Baylor Research Institute 15 participants Est. completion 2026-12-30 3 sites Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT05653232

    Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

    Not yet reported Johns Hopkins University 120 participants Est. completion 2028-03 9 sites Stand-alone
    Other conditions: HCV
    View official trial listing →
  • Recruiting NCT NCT06159504

    Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

    Not yet reported Médecins du Monde 3040 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Hepatitis C, RDT
    View official trial listing →
  • Recruiting NCT NCT06180590

    The Efficacy of Vosevi in Treating DAA-experienced Patients

    The Third Affiliated Hospital of Guangzhou Medical University 200 participants Est. completion 2027-02-28 1 site
    Other conditions: Chronic Hepatitis C, Medication Reaction
    View official trial listing →
  • Recruiting NCT NCT06306300

    Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)

    Not yet reported Oswaldo Cruz Foundation 30000 participants Est. completion 2026-12-31 2 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Recruiting NCT NCT06953479

    Implementing Low-Barrier HCV Treatment in a Jail Setting

    Not yet reported Lifespan 40 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: HEPATITIS C (HCV), Incarceration, Injection Drug Use, Implementation Science
    View official trial listing →
  • Completed NCT NCT01457755

    Gilead Sustained Virologic Response (SVR) Registry

    Gilead Sciences 6625 participants Est. completion 2018-01-08 325 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT01457768

    A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

    Gilead Sciences 570 participants Est. completion 2018-04-09 323 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT01740791

    Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

    Not yet reported Gilead Sciences 103 participants Est. completion 2014-01-24 10 sites Stand-alone
    Other conditions: Chronic Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01817985

    A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

    Not yet reported Gilead Sciences 33 participants Est. completion 2013-08 6 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT01826981

    Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

    Not yet reported Gilead Sciences 359 participants Est. completion 2015-05 2 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT01858766

    Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

    Not yet reported Gilead Sciences 379 participants Est. completion 2014-08 51 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01909804

    Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

    Not yet reported Gilead Sciences 323 participants Est. completion 2014-08 49 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02002767

    Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment

    Not yet reported Gilead Sciences 19 participants Est. completion 2014-06-09 5 sites Stand-alone
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Status unknown NCT NCT02057003

    Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

    Valme University Hospital 1000 participants Est. completion 2020-12 1 site
    Other conditions: Hepatitis C, Chronic, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02064049

    Surveillance and Treatment of Prisoners With Hepatitis C

    Not yet reported Kirby Institute 3692 participants Est. completion 2019-11 4 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02185794

    Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

    Not yet reported Gilead Sciences 101 participants Est. completion 2015-09-28 11 sites Stand-alone
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02201901

    Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

    Not yet reported Gilead Sciences 268 participants Est. completion 2015-11 50 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02201940

    Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection

    Not yet reported Gilead Sciences 741 participants Est. completion 2015-09 80 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02201953

    Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

    Not yet reported Gilead Sciences 558 participants Est. completion 2015-12 76 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02202980

    Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

    Not yet reported Gilead Sciences 273 participants Est. completion 2016-05-09 2 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02220998

    Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

    Not yet reported Gilead Sciences 269 participants Est. completion 2015-09 51 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Terminated NCT NCT02292706

    A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

    Gilead Sciences 1609 participants Est. completion 2021-12-31 138 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02300103

    Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

    Not yet reported Gilead Sciences 69 participants Est. completion 2016-09-15 30 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02333292

    Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

    Valme University Hospital 1128 participants Est. completion 2017-06-30 1 site
    Other conditions: Chronic Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT02336139

    A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use

    Not yet reported Kirby Institute 103 participants Est. completion 2018-11-28 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02346721

    Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

    Not yet reported Gilead Sciences 111 participants Est. completion 2016-06-15 61 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02378935

    Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

    Not yet reported Gilead Sciences 205 participants Est. completion 2016-04-12 34 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02378961

    Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

    Not yet reported Gilead Sciences 128 participants Est. completion 2016-01-26 34 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02468648

    Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72 participants Est. completion 2018-09-14 1 site
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02480712

    Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

    Not yet reported Gilead Sciences 107 participants Est. completion 2016-06-22 15 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Terminated NCT NCT02510300

    A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

    Gilead Sciences 461 participants Est. completion 2023-01-06 51 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02533427

    Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

    Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 site
    Other conditions: HCV Infection
    View official trial listing →
  • Completed NCT NCT02536313

    Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen

    Not yet reported Gilead Sciences 49 participants Est. completion 2016-06-28 1 site
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02607735

    Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

    Not yet reported Gilead Sciences 416 participants Est. completion 2017-06-21 86 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02607800

    Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

    Not yet reported Gilead Sciences 943 participants Est. completion 2017-01-11 93 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02625909

    Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.

    Not yet reported Kirby Institute 222 participants Est. completion 2020-03-23 25 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02639247

    Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

    Not yet reported Gilead Sciences 333 participants Est. completion 2017-01-18 78 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02639338

    Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis

    Not yet reported Gilead Sciences 220 participants Est. completion 2017-01-02 70 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT02657694

    Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

    FixHepC 10000 participants Est. completion 2018-06-30 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02671500

    Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

    Not yet reported Gilead Sciences 375 participants Est. completion 2018-03-27 38 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02722837

    Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection

    Not yet reported Gilead Sciences 119 participants Est. completion 2017-09-13 15 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02728206

    Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation

    Not yet reported Gilead Sciences 9 participants Est. completion 2018-01-16 1 site
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02745535

    Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

    Not yet reported University of Maryland, Baltimore 77 participants Est. completion 2018-10-24 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02781558

    Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis

    Not yet reported Gilead Sciences 204 participants Est. completion 2017-10-27 28 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02781571

    Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

    Not yet reported Gilead Sciences 79 participants Est. completion 2017-07-28 15 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02822794

    Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

    Not yet reported Gilead Sciences 117 participants Est. completion 2017-08-25 18 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02825212

    Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia

    Not yet reported, Not yet reported Icahn School of Medicine at Mount Sinai 10 participants Est. completion 2019-07-19 1 site Stand-alone
    Other conditions: Hepatitis C, Cryoglobulinemia
    View official trial listing →
  • Completed NCT NCT02836925

    Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection

    Not yet reported Fondazione Italiana Linfomi - ETS 40 participants Est. completion 2022-11 13 sites Stand-alone
    Other conditions: Indolent B-cell Lymphoma, Hepatitis C
    View official trial listing →
  • Completed NCT NCT02938013

    deLIVER: Direct Acting Antiviral Effects on the Liver

    Not yet reported Johns Hopkins University 15 participants Est. completion 2020-09-30 1 site Stand-alone
    Other conditions: HCV Coinfection, Liver Disease, HIV
    View official trial listing →
  • Completed NCT NCT02994056

    Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

    Not yet reported Gilead Sciences 32 participants Est. completion 2018-12-12 12 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT02996682

    Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

    Not yet reported Gilead Sciences 102 participants Est. completion 2018-05-08 33 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT03018353

    Curing HCV in Incarcerated Patients

    Not yet reported San Francisco Department of Public Health 100 participants Est. completion 2018-06-04 1 site
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT03022981

    Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection

    Not yet reported Gilead Sciences 216 participants Est. completion 2020-02-26 27 sites Stand-alone
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT03032666

    Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial

    Not yet reported Ala'a Sharara 7 participants Est. completion 2018-08-06 1 site Stand-alone
    Other conditions: Thalassemia, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03036852

    Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease

    Not yet reported Gilead Sciences 59 participants Est. completion 2018-11-07 22 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT03057847

    Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection

    Not yet reported Elizabeth Krans, MD 32 participants Est. completion 2022-02-24 1 site Stand-alone
    Other conditions: Hepatitis C, Chronic, Opioid-use Disorder
    View official trial listing →
  • Completed NCT NCT03074331

    Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

    Not yet reported Gilead Sciences 130 participants Est. completion 2018-02-07 16 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT03086044

    Transplanting Hepatitis C Positive Organs

    Not yet reported Brigham and Women's Hospital 148 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Hepatitis C, Awaiting Organ Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT03112044

    Lung Transplant HCV, Pilot Study

    Not yet reported University Health Network, Toronto 26 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Lung Transplant Infection, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03118843

    Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

    Not yet reported Gilead Sciences 31 participants Est. completion 2018-03-19 27 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Status unknown NCT NCT03164902

    Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence

    Not yet reported Proteus Digital Health, Inc. 253 participants Est. completion 2019-04-30 16 sites Stand-alone
    Other conditions: Hepatitis C, Chronic, Nonadherence, Patient
    View official trial listing →
  • Terminated NCT NCT03207399

    Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment

    Not yet reported Duke University 1 participants Est. completion 2019-03-25 1 site
    Other conditions: Hepatitis C, Chronic, Lung Transplant
    View official trial listing →
  • Terminated NCT NCT03208127

    DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant

    Not yet reported Massachusetts General Hospital 33 participants Est. completion 2021-06-04 1 site
    Other conditions: End Stage Liver Disease, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03222531

    Expanding the Pool in Orthotopic Heart Transplantation

    Not yet reported Mary E. Keebler, MD 20 participants Est. completion 2026-06-02 1 site Stand-alone
    Other conditions: Hepatitis C, Heart Transplant, Cardiac Transplant
    View official trial listing →
  • Completed NCT NCT03235154

    A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

    Not yet reported Community Research Initiative of New England 11 participants Est. completion 2019-09-26 1 site
    Other conditions: Hepatitis C, Chronic, Hepatitis C, Opiate Dependence
    View official trial listing →
  • Completed NCT NCT03249194

    Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients

    Not yet reported Virginia Commonwealth University 25 participants Est. completion 2020-03-15 1 site Stand-alone
    Other conditions: Kidney Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03250910

    Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

    Not yet reported National Taiwan University Hospital 228 participants Est. completion 2017-10-31 2 sites Stand-alone
    Other conditions: Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus
    View official trial listing →
  • Withdrawn NCT NCT03313414

    HCV Post-Exposure Prophylaxis for Health Care Workers

    Not yet reported Massachusetts General Hospital Est. completion 2020-01-16 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT03377478

    Expanding the Pool in Lung Transplantation

    Not yet reported Pablo Sanchez 10 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Hepatitis C, Lung Transplant
    View official trial listing →
  • Withdrawn NCT NCT03389061

    Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet

    Not yet reported Radboud University Medical Center Est. completion 2019-03-22 3 sites Stand-alone
    Other conditions: HCV
    View official trial listing →
  • Completed NCT NCT03423641

    An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

    Kaiser Permanente 33808 participants Est. completion 2017-12-31
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Terminated NCT NCT03483987

    Re-treatment of HCV Following DAA Failure

    Not yet reported Sanjay Gandhi Postgraduate Institute of Medical Sciences 18 participants Est. completion 2022-04-30 2 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT03492112

    A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams

    Not yet reported Kirby Institute 101 participants Est. completion 2021-11-30 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT03501550

    Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

    Not yet reported Cocrystal Pharma, Inc. 12 participants Est. completion 2019-06-07 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT03512210

    Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 400 participants Est. completion 2021-02-28 38 sites Stand-alone
    Other conditions: Hepatitis C, HIV-1-infection, Liver Diseases
    View official trial listing →
  • Completed NCT NCT03513393

    Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.

    Not yet reported Radboud University Medical Center 11 participants Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Hepatitis C, Swallowing Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT03520660

    People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121 participants Est. completion 2032-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Diabetes Mellitus, Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT03549312

    Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

    Not yet reported Saskatchewan Health Authority - Regina Area 25 participants Est. completion 2021-06-22 1 site Stand-alone
    Other conditions: HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence, Opioid Dependence, Bone Diseases, Metabolic, HIV/AIDS, Co-infection, Buprenorphine Dependence, HCV Coinfection
    View official trial listing →
  • Completed NCT NCT03570112

    Transmission of Chronic Hepatitis C in Pregnancy

    The Christ Hospital 40 participants Est. completion 2023-02-27 1 site
    Other conditions: Hepatitis C, Pregnancy Complications, Vertical Disease Transmission
    View official trial listing →
  • Completed NCT NCT03579576

    Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar

    Right to Care 803 participants Est. completion 2019-06-30 3 sites
    Other conditions: Hepatitis C, Hepatitis B, HIV Infections
    View official trial listing →
  • Completed NCT NCT03619837

    Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

    Not yet reported University of California, San Francisco 122 participants Est. completion 2020-08-13 6 sites Stand-alone
    Other conditions: Hepatitis C, Transplantation Disease Transmission
    View official trial listing →
  • Terminated NCT NCT03625687

    Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant

    Not yet reported Massachusetts General Hospital 19 participants Est. completion 2022-04-04 1 site Stand-alone
    Other conditions: Respiratory Failure, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03627546

    HCV Seek, Test and Rapid Treatment for Young PWID

    Not yet reported Weill Medical College of Cornell University 39 participants Est. completion 2021-06-30 1 site Stand-alone
    Other conditions: Hepatitis C, Drug Use
    View official trial listing →
  • Withdrawn NCT NCT03702218

    Hepatitis C Positive Donor Into Hepatitis C Negative Recipients

    Not yet reported University of Maryland, Baltimore Est. completion 2019-07-01 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT03724149

    Transplanting Hepatitis C Lungs Into Negative Lung Recipients

    Not yet reported, Not yet reported University of Pennsylvania 10 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Lung Diseases
    View official trial listing →
  • Status unknown NCT NCT03776760

    Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

    Kirby Institute 600 participants Est. completion 2022-08 4 sites
    Other conditions: Hepatitis C, Hepatitis, Liver Diseases, Hepatitis, Viral, Human, RNA Virus Infections, Digestive System Diseases
    View official trial listing →
  • Completed NCT NCT03801707

    Utilization of Hepatitis C Positive Kidneys in Negative Recipients

    Not yet reported, Not yet reported Ohio State University 54 participants Est. completion 2021-04-30 1 site Stand-alone
    Other conditions: Kidney Transplant, Hepatitis C, HCV
    View official trial listing →
  • Active, not recruiting NCT NCT03809533

    The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients

    Not yet reported Amit D Tevar, MD 30 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: Kidney Transplantation, Hepatitis C
    View official trial listing →
  • Completed NCT NCT03818308

    Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir

    Not yet reported Hannover Medical School 20 participants Est. completion 2021-06-08 14 sites Stand-alone
    Other conditions: Hepatitis C, Acute Hepatitis C
    View official trial listing →
  • Completed NCT NCT03819322

    The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

    Not yet reported Fernanda P Silveira, MD, MS 5 participants Est. completion 2025-03-17 1 site Stand-alone
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Terminated NCT NCT03820258

    Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

    Not yet reported Gilead Sciences 21 participants Est. completion 2020-02-19 10 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT03823911

    Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

    Not yet reported University of Maryland, Baltimore 87 participants Est. completion 2022-12-31 2 sites
    Cardiovascular disease Other conditions: Hepatitis C, Hiv
    View official trial listing →
  • Status unknown NCT NCT03887637

    Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

    Third Affiliated Hospital, Sun Yat-Sen University 180 participants Est. completion 2019-09-30
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT03888729

    Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)

    Not yet reported Partners in Health 100 participants Est. completion 2020-03 1 site Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT03891550

    Micro-elimination of Hepatitis C Virus Infection in Uremics

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 135 participants Est. completion 2024-04-15 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT03949764

    The Kentucky Viral Hepatitis Treatment Study

    Not yet reported Jennifer Havens 374 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Hepatitis C, Opioid-Related Disorders, Injection Drug Use
    View official trial listing →
  • Active, not recruiting NCT NCT03981445

    Integrated HIV Prevention and HCV Care for PWID

    Not yet reported Columbia University 446 participants Est. completion 2026-09-30 3 sites Stand-alone
    Other conditions: HIV Prevention, HCV, Opioid Use, Intravenous Drug Usage
    View official trial listing →
  • Completed NCT NCT03987503

    The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

    Not yet reported University of California, San Francisco 87 participants Est. completion 2022-12-29 1 site Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT04039698

    Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

    Not yet reported Hospital de Clinicas de Porto Alegre 144 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT04047680

    eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

    National Taiwan University Hospital 441 participants Est. completion 2019-06 2 sites
    Other conditions: Hepatitis C, Renal Disease, Viral Hepatitis C
    View official trial listing →
  • Completed NCT NCT04075916

    A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

    Not yet reported University of Pennsylvania 201 participants Est. completion 2026-02-25 11 sites Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT04112303

    Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

    Not yet reported Gilead Sciences 37 participants Est. completion 2021-06-25 22 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT04211909

    Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

    Not yet reported Gilead Sciences 87 participants Est. completion 2020-11-12 22 sites
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT04382404

    Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir

    Not yet reported Catherine Anne Chappell 11 participants Est. completion 2023-10-16 1 site Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT04653818

    HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial

    Not yet reported Alexandria University 84 participants Est. completion 2022-10-24 1 site
    Other conditions: Hepatocellular Carcinoma, Hepatitis C, Neoplasm Recurrence, Treatment Complication
    View official trial listing →
  • Status unknown NCT NCT04662138

    Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

    Alexandria University 100 participants Est. completion 2022-05-28 1 site
    Other conditions: Hepatitis C, Relapse, Antivirals
    View official trial listing →
  • Completed NCT NCT04664894

    Direct Acting Anti-Viral's In Chronic HCV Patients

    Getz Pharma 511 participants Est. completion 2019-05-30 1 site
    Other conditions: Safety Issues
    View official trial listing →
  • Completed NCT NCT04695769

    Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

    Not yet reported Helwan University 281 participants Est. completion 2021-10-21 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT04948801

    SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

    Third Affiliated Hospital, Sun Yat-Sen University 150 participants Est. completion 2021-12-30 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT04952207

    Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C

    Qing XIe 300 participants Est. completion 2021-08-31 11 sites
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT04997564

    The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

    Not yet reported Peking University First Hospital 120 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Chronic Hepatitis C, Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT05016609

    Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)

    Not yet reported Macfarlane Burnet Institute for Medical Research and Public Health Ltd 1800 participants Est. completion 2024-06 6 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT05092074

    Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection

    National Taiwan University Hospital 100 participants Est. completion 2023-02-28 15 sites
    Other conditions: Hepatitis C Virus Infection, Treatment Side Effects, Adherence, Treatment, Effect of Drug
    View official trial listing →
  • Active, not recruiting NCT NCT05140941

    Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy

    Not yet reported Catherine Anne Chappell 100 participants Est. completion 2027-06 9 sites Stand-alone
    Other conditions: Hepatitis C, Chronic, Pregnancy; Infection
    View official trial listing →
  • Enrolling by invitation NCT NCT05248919

    Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

    Not yet reported Queen Mary University of London 318 participants Est. completion 2027-09 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT05264558

    Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

    Not yet reported Macfarlane Burnet Institute for Medical Research and Public Health Ltd 606 participants Est. completion 2023-09-30 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT05467826

    Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis

    Not yet reported Peking University People's Hospital 100 participants Est. completion 2023-12-31 Stand-alone
    Other conditions: Hepatitis C, Cirrhosis
    View official trial listing →
  • Status unknown NCT NCT05474781

    Eliminating HCV Infection Among PWUD

    Vancouver Infectious Diseases Centre 300 participants Est. completion 2024-12-31 1 site
    Other conditions: Hepatitis C, Chronic, Drug Use
    View official trial listing →
  • Status unknown NCT NCT05503979

    Elimination of Hepatitis C Virus Among Users of Substances

    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 1000 participants Est. completion 2024-05-15
    Other conditions: Hepatitis C in Substance Users
    View official trial listing →
  • Terminated NCT NCT05717400

    Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

    Not yet reported M.D. Anderson Cancer Center 2 participants Est. completion 2024-08-29 1 site Stand-alone
    Other conditions: Liver Cancer
    View official trial listing →
  • Status unknown NCT NCT05895448

    Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

    Not yet reported Center For Hepatitis C, Atlanta, GA 125 participants Est. completion 2024-01-01 1 site Stand-alone
    Other conditions: Chronic Hepatitis C, People Who Inject Drugs
    View official trial listing →
  • Status unknown NCT NCT06533319

    Hepatitis C Treatment in Idaho County Jails

    Not yet reported Eastern Idaho Public Health 100 participants Est. completion 2025-08-01
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT06829966

    Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

    Assiut University 30 participants Est. completion 2024-08-30 1 site
    Other conditions: Intestinal Microbiota Between Different Groups
    View official trial listing →
  • Active, not recruiting NCT NCT06868264

    C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

    Not yet reported Atea Pharmaceuticals, Inc. 880 participants Est. completion 2026-12 105 sites
    Other conditions: HEPATITIS C VIRUS CHRONIC INFECTION
    View official trial listing →
  • Active, not recruiting NCT NCT07037277

    C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

    Not yet reported Atea Pharmaceuticals, Inc. 880 participants Est. completion 2027-03 107 sites
    Other conditions: HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
    View official trial listing →
  • Not yet recruiting NCT NCT07098481

    Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

    Not yet reported ANRS, Emerging Infectious Diseases 576 participants Est. completion 2028-06-30 Stand-alone
    Other conditions: Hepatitis C Virus Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07560046

    Combating Related Epidemics in HCV

    Not yet reported Duke University 1280 participants Est. completion 2030-12-30 Stand-alone
    Other conditions: HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV)
    View official trial listing →
  • Active, not recruiting NCT NCT07565948

    Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment

    Xiangya Hospital of Central South University 200 participants Est. completion 2027-12-31 1 site
    Other conditions: Hepatitis C Virus (HCV)
    View official trial listing →
  • Not yet recruiting NCT NCT07793643

    AI-Powered Hepatitis C Single-Encounter Test-and-Treat

    Not yet reported Patrick Grace 35 participants Est. completion 2028-09-01 1 site Stand-alone
    Other conditions: HEPATITIS C (HCV)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Velpatasvir, Epclusa

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.